| Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman, S Lang, V Albert, ... Circulation 132 (2), 82-92, 2015 | 219 | 2015 |
| SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis AL Bailey, O Dmytrenko, L Greenberg, AL Bredemeyer, P Ma, J Liu, ... Basic to Translational Science 6 (4), 331-345, 2021 | 183 | 2021 |
| Inverse remodelling of K2P3. 1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific … C Schmidt, F Wiedmann, XB Zhou, J Heijman, N Voigt, A Ratte, S Lang, ... European Heart Journal 38 (22), 1764-1774, 2017 | 106 | 2017 |
| The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation C Schmidt, J Kisselbach, PA Schweizer, HA Katus, D Thomas Vascular health and risk management, 193-202, 2011 | 88 | 2011 |
| Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation FE Fakuade, V Steckmeister, F Seibertz, J Gronwald, S Kestel, J Menzel, ... Cardiovascular research 117 (7), 1790-1801, 2021 | 67 | 2021 |
| Stretch-activated two-pore-domain (K2P) potassium channels in the heart: Focus on atrial fibrillation and heart failure C Schmidt, F Wiedmann, SM Kallenberger, A Ratte, JS Schulte, B Scholz, ... Progress in biophysics and molecular biology 130, 233-243, 2017 | 56 | 2017 |
| Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels C Schmidt, F Wiedmann, PA Schweizer, R Becker, HA Katus, D Thomas Naunyn-Schmiedeberg's archives of pharmacology 385, 1003-1016, 2012 | 52 | 2012 |
| Piezo1 and BKCa channels in human atrial fibroblasts: Interplay and remodelling in atrial fibrillation D Jakob, A Klesen, B Allegrini, E Darkow, D Aria, R Emig, AS Chica, ... Journal of Molecular and Cellular Cardiology 158, 49-62, 2021 | 51 | 2021 |
| Ion channel dysfunctions in dilated cardiomyopathy in limb-girdle muscular dystrophy I El-Battrawy, Z Zhao, H Lan, X Li, G Yücel, S Lang, K Sattler, ... Circulation: Genomic and Precision Medicine 11 (3), e001893, 2018 | 51 | 2018 |
| Cloning, functional characterization, and remodeling of K2P3. 1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure C Schmidt, F Wiedmann, C Langer, F Tristram, P Anand, W Wenzel, ... Heart Rhythm 11 (10), 1798-1805, 2014 | 50 | 2014 |
| Axial Tubule Junctions Activate Atrial Ca2+ Release Across Species S Brandenburg, J Pawlowitz, FE Fakuade, D Kownatzki-Danger, T Kohl, ... Frontiers in Physiology 9, 1227, 2018 | 49 | 2018 |
| Inhibition of cardiac two-pore-domain K+ (K2P) channels–an emerging antiarrhythmic concept C Schmidt, F Wiedmann, PA Schweizer, HA Katus, D Thomas European Journal of Pharmacology 738, 250-255, 2014 | 48 | 2014 |
| Cardiac expression and atrial fibrillation-associated remodeling of K2P2. 1 (TREK-1) K+ channels in a porcine model C Schmidt, F Wiedmann, F Tristram, P Anand, W Wenzel, P Lugenbiel, ... Life sciences 97 (2), 107-115, 2014 | 47 | 2014 |
| Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular system F Wiedmann, C Schmidt, P Lugenbiel, I Staudacher, AK Rahm, C Seyler, ... Clinical Science 130 (9), 643-650, 2016 | 46 | 2016 |
| Expression and function of Kv1. 1 potassium channels in human atria from patients with atrial fibrillation E Glasscock, N Voigt, MD McCauley, Q Sun, N Li, DY Chiang, XB Zhou, ... Basic research in cardiology 110, 1-15, 2015 | 45 | 2015 |
| Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy F Wiedmann, C Beyersdorf, XB Zhou, M Kraft, A Paasche, N Jávorszky, ... Cardiovascular Research 118 (7), 1728-1741, 2022 | 40 | 2022 |
| Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1 F Wiedmann, JS Schulte, B Gomes, MP Zafeiriou, A Ratte, F Rathjens, ... Basic Research in Cardiology 113, 1-14, 2018 | 40 | 2018 |
| Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels C Schmidt, F Wiedmann, PA Schweizer, R Becker, HA Katus, D Thomas European journal of pharmacology 721 (1-3), 237-248, 2013 | 40 | 2013 |
| Small Conductance Ca2 +-Activated K+ (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation … E Darkow, TT Nguyen, M Stolina, FA Kari, C Schmidt, F Wiedmann, ... Frontiers in physiology 12, 650964, 2021 | 38 | 2021 |
| Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K+ Channel–Related Acid-Sensitive K+ Channel-1) (K2P3.1) K+ Channels … C Schmidt, F Wiedmann, C Beyersdorf, Z Zhao, I El-Battrawy, H Lan, ... Circulation: Arrhythmia and Electrophysiology 12 (9), e007465, 2019 | 36 | 2019 |